Compare Huntington Bancshares Incorporated (HBAN) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Philip Morris International Inc. — how do they compare? Huntington Bancshares Incorporated trades at $15.26 (market cap $31.04B), while Philip Morris International Inc. trades at $200.42 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 10.1× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (4.04%). Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Philip Morris International Inc. for 85 Days on average.
| HBAN | PM | |
|---|---|---|
Market Cap | $31.04B | $312.50B |
Volume | 23,864,172 | 5,517,172 |
Sector | Financials | Consumer Staples |
52-Week High | $19.27 | $200.50 |
52-Week Low | $15.02 | $144.33 |
Typical Hold Time | 52 Days | 85 Days |
Enterprise Value | $49.57B | $355.62B |
Dividend Yield | 4.04% | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, with a bearish technical signal. The company reported mixed quarterly earnings, missing in Q4 2025 and Q2 2026 but beating in Q1 2026, while revenue grew to $8.13B in 2025. Analyst consensus is split evenly between Buy and Hold, with a $19.60 price target suggesting upside. Recent news highlights margin pressures from higher interest rates and a revised 2027 outlook.
HBAN offers value with a P/E of 11.82 and pays a dividend, but faces headwinds from net interest margin compression and loan growth challenges. The stock's near-term performance hinges on Q3 2026 earnings and management's ability to navigate rate environment pressures.
Philip Morris International (PM) trades at $192.69, up 1.2% today, with a bullish technical signal and strong analyst support. Recent Q2 2026 EPS beat expectations at $2.20 vs. $2.05, and revenue growth accelerated to $40.65B in 2025. The company's smoke-free products now drive 42% of revenue, with ZYN and IQOS expansions fueling optimism. Cash flow remains robust, with 2026 operating cash flow projected at $14.3B, supporting dividend growth.
Outlook is positive given earnings momentum and smoke-free transition, but high debt ($42.17B long-term) and regulatory risks persist. The consensus price target of $212.17 implies ~10% upside, though valuation multiples are elevated versus peers. Key risks include FX volatility and slower adoption of next-gen products.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
